Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 3/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 2/20 | 0.48 |
| ▸ | CCR3 | P51677 | 1/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 2/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5974110 | 0.98 | ACHE (0.49) | KMT2AMEN1TSHRSIGMAR1GAA | |
| Hydrochloric Acid SCHEMBL5974104 | 0.98 | ACHE (0.49) | KMT2AMEN1TSHRSIGMAR1GAA | |
| SCHEMBL27799682 | 0.87 | KMT2A (0.52) | KMT2AMEN1TSHRSIGMAR1ACHE | |
| SCHEMBL350620 | 0.85 | SIGMAR1 (0.48) | SIGMAR1ACHEBCHE | |
| SCHEMBL16882456 | 0.84 | S1PR5 (0.53) | KMT2AMEN1TSHRSIGMAR1S1PR5 | |
| SCHEMBL30493801 | 0.84 | SIGMAR1 (0.53) | KMT2AMEN1SIGMAR1ACHEFAAH | |
| SCHEMBL350213 | 0.84 | FKBP1A (0.47) | KMT2AMEN1TSHRSIGMAR1ACHE | |
| SCHEMBL15836211 | 0.83 | CYP2D6 (0.47) | KMT2AMEN1TSHRSIGMAR1ACHE | |
| Hydrochloric Acid SCHEMBL17611756 | 0.83 | FKBP1A (0.47) | KMT2AMEN1TSHRSIGMAR1ACHE | |
| SCHEMBL184071 | 0.83 | MEN1 (0.56) | KMT2AMEN1SIGMAR1ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112010797-A | Benzazepine polycyclic compound and synthetic method thereof | 江阴迈康升华医药科技有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-106458996-B | Fused pyrimidines as inhibitors of the p97 complex | 克里弗生物科学公司 | 2020-11-03 | — | — | CN | disclosed |
| CN-109867667-A | The bis- target spot inhibitor of PARP and PI3K containing Pyridopyrimidine structure | 中国药科大学 | 2019-06-11 | — | — | CN | disclosed |
| CN-109206361-A | The improvement preparation method of useful intermediates chirality 3- amino piperidine for tropsch imatinib preparation | 意大利合成制造有限公司 | 2019-01-15 | — | — | CN | disclosed |
| CN-107848971-A | Heterocyclic compound | 武田药品工业株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-107108625-A | Spirocyclic derivatives | 克罗诺斯治疗有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107011330-A | BRUTON'S TYROSINE KINASE INHIBITORS | 比奥根MA公司 | 2017-08-04 | — | — | CN | disclosed |
| CN-107001367-A | 2- [ bis (4-fluorophenyl) methyl ] -2, 7-diazaspiro [4.5] decan-10-one derivatives and related compounds as inhibitors of human Dopamine Active Transporter (DAT) protein for the treatment of e.g. Attention Deficit Disorder (ADD) | 克罗诺斯治疗有限公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-104817561-B | The Piperidine inhibitors of JAK3 | 奥斯拜客斯制药有限公司 | 2017-06-13 | — | — | CN | disclosed |
| CN-104402879-B | Octahydro-1H-pyrrolo[2, 3-c]pyridine derivative, octahydro-1H-pyrrolo[3, 2-c]pyridine derivative and preparation methods thereof | 丽水绿氟科技有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-101357915-A | Diazabicyclic central nervous system active agents | ABBOTT LAB (US) | 2009-02-04 | — | — | CN | disclosed |
| CN-100430398-C | Diazabicyclic central nervous system active agents | ABBOTT LAB (US) | 2008-11-05 | — | — | CN | disclosed |
| CN-101277700-A | Pyrimidine compounds as serotonin receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-01 | — | — | CN | disclosed |
| CN-100355755-C | Diazabicyclic central nervous system active agents | ABBOTT LAB (US) | 2007-12-19 | — | — | CN | disclosed |
| CN-101005877-A | Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | MERCK & CO INC (US) | 2007-07-25 | — | — | CN | disclosed |
| CN-1765899-A | Diazabicyclic central nervous system active agents | ABBOTT LAB (US) | 2006-05-03 | — | — | CN | disclosed |
| WO-2005042537-A1 | PHENYL-ANILINE SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-05-12 | — | — | WO | disclosed |
| CN-1142141-C | Ethanesulfonyl-piperidine derivatives | - | 2004-03-17 | — | — | CN | disclosed |
| CN-1440410-A | Diazabicyclic central nervous system active agents | ABBOTT LAB (US) | 2003-09-03 | — | — | CN | disclosed |
| CN-1354745-A | Ethanesulfonyl-piperidine derivatives | HOFFMANN LA ROCHE (CH) | 2002-06-19 | — | — | CN | disclosed |